Interim report
Page 1
Octo ber 29, 2026 The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor Plot No. C1, ‘G’ Block, Bandra-Kurla Complex Bandra (East), Mumbai 400 051. Sy mbol: RPGLIFE BSE Limited Corporate Relationship Department Floor 25, P.J. Towers Dalal Street Mumbai 400 001. Sc rip code: 532983 Dear Sir/Madam, Sub: Outcome of Board Meeting of the Company held on October 29, 2026. Pursuant to the provisions of Regulations 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and such other rules and regulations, as may be applicable, this is to inform you that the Board of Directors (‘Board’) of the Company at its meeting held today, which commenced at 03:00 PM (IST) and concluded at 06:50 PM (IST), inter-alia, unanimously approved/consented to/ took on record, the following: A. Unaudited Financial Results Unaudited Financial Results (Standalone and Consolidated) of the Company, for the quarter and half ended September 30, 2026, which are enclosed herewith, together with the respective Limited Review Report(s) issued by the Statutory Auditors of the Company. B. Revised Policy on Related Party Transactions The amended Policy on Related Party Transaction s will be available on the website of the Company www.rpglifesciences.com. Information pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, read with relevant SEBI Circular(s) are enclosed herewith. The above information will also be available on the website of the Company www.rpglifesciences.com. The trading window for dealing in securities of the Company, shall open post 48 hours after declaration of the aforesaid Financial Results of the Company. Kindly take the same on record. Thanking you, Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary Encl.- as above